TidemaxxingTidemaxxing
5-Amino-1MQ Capsules
Fat Loss

Order 5-Amino-1MQ Capsules — 50 mg · ×60 capsules

≥98% HPLC purity · lot-matched CoA · sealed under nitrogen

Body-composition research structured for glucose-insulin coupling in rodent models.

5-Amino-1MQ is a small-molecule inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme central to NAD+ salvage and methyl-donor balance. It is actively studied in obesity, metabolic, and sarcopenia research.

$107.99$119.99SAVE 10%
USD · ships lyophilized · discount auto-applied
Buy 5-Amino-1MQ Capsules now →
fat-lossmetabolicglp-1
Oral format

Capsule composition

Each bottle ships sealed with a lot-matched certificate of analysis covering per-capsule purity.

50 mg · ×60 capsules
Per capsule
50 mg
Count
60
Total active
3000 mg
Price
$107.99
$ per mg
$2.16
Primer

Mechanism in the literature

NNMT consumes both nicotinamide (an NAD+ precursor) and SAM (the universal methyl donor). Inhibiting NNMT raises nicotinamide availability for NAD+ synthesis and preserves SAM pools — a mechanism proposed to support both metabolic and muscle-biology endpoints.

From the same shelf

Often paired with

Buyers viewing 5-Amino-1MQ Capsules typically also consider 5-Amino-1MQ, Tirzepatide and AICAR. Each is in stock, sealed under nitrogen with a lot-matched CoA.

What it's used for

Research use-cases

  • NNMT inhibitor — small molecule, not a peptide
  • Raises NAD+ precursor availability via NNMT blockade
  • Studied in adipocyte, muscle, and metabolic research
  • Available in oral capsule and injectable research formats
Protocol notes

Handling in the lab

Both oral and injectable research routes appear in the literature. Oral capsule formats are convenient for multi-week protocols.

At a glance

Key facts

  • NNMT inhibitor — small molecule, not a peptide
  • Raises NAD+ precursor availability via NNMT blockade
  • Studied in adipocyte, muscle, and metabolic research
  • Available in oral capsule and injectable research formats
Questions we get

Frequently asked

Is 5-Amino-1MQ a peptide?

No — it is a small-molecule NNMT inhibitor (a quinoline derivative), not a peptide. It appears in peptide-research catalogs because it targets NAD+-adjacent biology.

What is NNMT?

Nicotinamide N-methyltransferase — an enzyme that consumes nicotinamide and SAM to produce N-methylnicotinamide. Elevated NNMT activity is linked to obesity in research models.

Oral or injectable?

Both formats are used. Oral capsules suit longer research windows; injectable is used when fast PK is desired.

How does it interact with NAD+ supplementation?

NNMT blockade increases the nicotinamide pool available for NAD+ synthesis — a complementary mechanism to direct NAD+/NMN supplementation.

More Fat Loss compounds

Related reading